Lifestyle Intervention and Risk for MI, Heart Failure in T2D
An intensive lifestyle intervention was found to be associated with a significant loss of fat mass and lean mass in adults with type 2 diabetes.
All articles by Endocrinology Advisor Contributing Writer
Anti-VEGF Therapy May Not Improve Outcomes in Diabetic Macular Edema
Researchers found that, following anti-VEGF therapy, patients with DME mainted retinal thickness, but lost letters of visual acuity at 2 and 5 year follow-up appointments.
ESC Working Group on Cardiovascular Pharmacotherapy Releases Recommendations for Lipid Management in RA
The position paper developed by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy provides recommendations for lipid management in rheumatoid arthritis.
Elevated TSH in Patients With Heart, Renal Failure Is Not Always Indicative of Thyroid Disorder
Elevated levels of thyrotropin in patients with a history of chronic heart or renal failure may not always indicate thyroid disease.
Comparing Radiofrequency and Laser Ablation for Thyroid Nodule Volume Reduction
Radiofrequency ablation and laser ablation are both safe and very effective for reducing the volume of thyroid nodules.
Predictors of Biochemical Response to Antithyroid Drugs in Graves Disease
Researchers identified predictors of biochemical treatment response to antithyroid drugs, specifically methimazole, in patients with Graves disease.
Disparities in Racial, Ethnic Outcomes in Differentiated Thyroid Cancer Remain in the AJCC Staging System
The 8th edition of the American Joint Committee on Cancer staging system does not address disparities in outcomes in differentiated thyroid cancer.
Elevated Thyrotropin Levels Associated With Severe Depression
Severe depression is associated with higher thyrotropin levels, according to results of a historical cohort study conducted at the University of Utah.
Does Vitamin D Status Affect Risk for Thyroid Immune-Related AEs With Immune Checkpoint Inhibitors?
Vitamin D status was not linked to risk for thyroid immune-related adverse events in patients initiating immune checkpoint inhibitor therapy.
Liraglutide Not Associated With Worse CV Outcomes in Patients With HF History
Treatment with liraglutide for type 2 diabetes was not associated with an increased risk for hospitalization for heart failure (HF) or cardiovascular death in patients with vs without a history of HF.
-
Loading...
-
Loading...
Next post in Type 2 Diabetes
